Paola Di Carlo | Medicine and Health Sciences | Best Review Paper Award

Published on by Environmental Scientists

Best Review Paper Award

Paola Di Carlo
University of Palermo, Italy

Paola Di Carlo
Affiliation University of Palermo, IT
Country Italy
Scopus ID 6604018676
Documents 147
Citations 2368
h-index 25
Subject Area Medicine and Health Sciences
Event International Environmental Scientists Award
ORCID 0000-0003-4418-5855

Paola Di Carlo is an Italian researcher affiliated with the University of Palermo whose scientific work spans microbiology, infectious diseases, microbiome research, nanomedicine, antimicrobial resistance, and translational medicine. Through a substantial publication record and multidisciplinary collaborations, she has contributed to the advancement of knowledge concerning microbial ecology, cancer-related microbiota, respiratory infections, and innovative therapeutic strategies. Her scholarly profile demonstrates sustained engagement with emerging topics in medicine and health sciences, making her a notable candidate for recognition through the Best Review Paper Award within the International Environmental Scientists Award program.[1]

Abstract

This article reviews the academic profile, publication achievements, and scientific contributions of Paola Di Carlo. Her research portfolio reflects a strong commitment to understanding microbiological processes involved in human disease, including microbiome dysbiosis, antimicrobial resistance, respiratory pathogens, and cancer-associated microbial ecosystems. Recent publications emphasize review-based synthesis of emerging evidence and provide clinically relevant perspectives for researchers and healthcare professionals.[2]

Keywords

Microbiome Research, Antimicrobial Resistance, Infectious Diseases, Nanomedicine, Biliary Cancer, Translational Medicine, Clinical Microbiology, Review Articles, Medical Sciences, Evidence Synthesis.

Introduction

Modern biomedical research increasingly relies on interdisciplinary approaches that integrate microbiology, clinical medicine, molecular biology, and public health. Within this landscape, Paola Di Carlo has developed a research portfolio characterized by scientific rigor and relevance to contemporary healthcare challenges. Her publications explore the relationship between microbial communities and disease progression, while also assessing therapeutic innovations and preventive strategies.[3]

Research Profile

With 147 indexed publications, 2,368 citations, and an h-index of 25, Di Carlo has established a substantial scholarly presence within medicine and health sciences. Her work frequently addresses microbiological determinants of disease, antimicrobial stewardship, pathogen surveillance, and microbiome-mediated mechanisms. The breadth of her research demonstrates both clinical relevance and translational value across multiple healthcare domains.[1]

Research Contributions

  • Investigation of microbiome dysbiosis and its implications for cancer development and therapeutic interventions.
  • Research on multidrug-resistant pathogens and innovative antimicrobial approaches.
  • Evaluation of lipid nanoparticle systems to enhance antibiofilm activity and drug delivery.
  • Clinical studies involving Legionella pneumophila infections and epidemiological assessment.
  • Comprehensive review articles synthesizing current evidence on biliary and pancreatic tract diseases.

Publications

  • Polyphenols and ADPKD: A Further Aid from Nature? Life (2026).
  • Biliary Tract and Pancreatic Cancer (BTPC) in Adult Patients: The Role of the Biliary Microbiota in Cancer and Therapeutic Strategies—A Scoping Review. Cancers (2026).
  • Multicomponent Lipid Nanoparticles as a Tool to Potentially Improve the Antibiofilm Activity of Resveratrol against MDR Clinical Isolates. ACS Omega (2026).
  • Microbiome Dysbiosis, Chemoprophylaxis, and Tumor Microenvironment in Biliary–Pancreatic Tract Diseases.
  • Community-Acquired Legionella pneumophila Pneumonia: A Case-Control Study in Adult Inpatients from 2019 to 2024. Pathogens (2025).

Research Impact

The impact of Di Carlo’s research is reflected through consistent citation activity, interdisciplinary collaborations, and publication in internationally recognized journals. Her review articles provide valuable syntheses of emerging evidence, enabling clinicians and researchers to better understand disease mechanisms and potential treatment pathways. Such contributions support evidence-based healthcare decision-making and stimulate future research initiatives.[4]

Award Suitability

Paola Di Carlo demonstrates qualities commonly associated with recipients of review-focused academic distinctions. Her ability to consolidate complex scientific evidence, identify knowledge gaps, and communicate research findings in accessible scholarly formats contributes significantly to the advancement of medicine and health sciences. The depth and relevance of her recent review publications align strongly with the objectives of the Best Review Paper Award.[5]

Conclusion

Paola Di Carlo has developed a distinguished academic record characterized by productive scholarship, interdisciplinary engagement, and meaningful contributions to microbiology and medical research. Her publication portfolio, citation impact, and emphasis on comprehensive review-based scholarship provide a strong foundation for recognition within international scientific award programs. The available evidence supports her suitability for acknowledgment through the Best Review Paper Award.

References

  1. Elsevier. (n.d.). Scopus author details: Paola Di Carlo, Author ID 6604018676. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=6604018676
  2. Di Carlo, P. et al. (2026). Polyphenols and ADPKD: A Further Aid from Nature? Life.
    https://doi.org/10.3390/life16061022
  3. Di Carlo, P. et al. (2026). Biliary Tract and Pancreatic Cancer in Adult Patients: A Scoping Review. Cancers.
    https://doi.org/10.3390/cancers18121875
  4. Di Carlo, P. et al. (2026). Multicomponent Lipid Nanoparticles and Antibiofilm Activity. ACS Omega.
    https://doi.org/10.1021/acsomega.5c12649
  5. Di Carlo, P. (2026). Microbiome Dysbiosis, Chemoprophylaxis, and Tumor Microenvironment in Biliary–Pancreatic Tract Diseases. OSF.
    https://doi.org/10.17605/osf.io/uc34p
  6. Di Carlo, P. et al. (2025). Community-Acquired Legionella pneumophila Pneumonia: A Case-Control Study in Adult Inpatients from 2019 to 2024. Pathogens.
    https://doi.org/10.3390/pathogens15010013

Gea Oliveri Conti | Medicine and Health Sciences | Pioneer Researcher Award

Published on by Environmental Scientists

Pioneer Researcher Award

Gea Oliveri Conti
University of Catania
Gea Oliveri Conti
Affiliation University of Catania
Country Italy
Scopus ID 24332549000
Documents 185
Citations 9531
h-index 56
Subject Area Medicine and Health Sciences
Event Environmental Scientists Award
ORCID 0000-0003-1857-8612

Gea Oliveri Conti distinguished scientific contributions and sustained scholarly impact in the fields of environmental sciences, medicine, and public health research. Gea Oliveri Conti of the University of Catania has established a notable academic profile through multidisciplinary investigations related to environmental exposure assessment, toxicology, epidemiology, and health risk analysis.[1] Her research activities have contributed to the advancement of evidence-based environmental health studies and international scientific collaboration.[2]

Abstract

Gea Oliveri Conti has contributed extensively to environmental and biomedical sciences through interdisciplinary investigations focusing on environmental contamination, toxicological evaluation, biomonitoring, and public health assessment. Her scholarly work addresses the interaction between environmental pollutants and human health outcomes, with particular emphasis on exposure pathways, ecological sustainability, and preventive healthcare strategies.[1] The Pioneer Researcher Award acknowledges her scientific productivity, citation influence, and leadership in advancing environmental health research within international academic communities.[3]

Keywords

Environmental Health, Toxicology, Biomonitoring, Public Health, Epidemiology, Environmental Exposure, Health Risk Assessment, Pollution Studies, Medical Sciences, Sustainable Environment

Introduction

Environmental health research has become increasingly important in addressing the complex relationships between ecological conditions and human wellbeing. Scientific investigations in this domain contribute to understanding environmental pollutants, exposure risks, and sustainable mitigation strategies. Researchers working at the intersection of medicine and environmental sciences provide essential knowledge for evidence-based public health policies and preventive healthcare systems.[2]

Within this context, Gea Oliveri Conti has developed a recognized body of scholarly work involving toxicological assessment, epidemiological studies, and environmental exposure analysis. Her research portfolio demonstrates a sustained commitment to interdisciplinary scientific inquiry and international collaboration in medicine and environmental sciences.[1]

Research Profile

Gea Oliveri Conti is affiliated with the University of Catania, Italy, where her academic activities encompass environmental medicine, toxicological sciences, and public health research. According to available Scopus author metrics, her scholarly profile includes 185 indexed documents, more than 9,500 citations, and an h-index of 56.[1] These indicators reflect both sustained research productivity and substantial influence within the scientific community.

Her research interests include biomonitoring methodologies, environmental exposure pathways, heavy metal contamination, ecological health evaluation, and epidemiological risk analysis. The integration of laboratory-based investigations and population health studies has contributed to broader understanding of environmental determinants affecting human health outcomes.[4]

Research Contributions

The scientific contributions of Gea Oliveri Conti span multiple interdisciplinary domains associated with environmental medicine and public health sciences. Her investigations frequently address pollution monitoring, environmental toxicology, biomarker analysis, and ecological sustainability.[3]

  • Development of environmental exposure assessment methodologies for evaluating pollutant-related health risks.
  • Research involving biomonitoring and toxicological characterization of environmental contaminants.

Publications

Selected publications and indexed scholarly works associated with Gea Oliveri Conti demonstrate sustained research engagement in environmental sciences and health-related disciplines.[5]

  • Studies related to environmental biomonitoring and heavy metal exposure assessment.
  • Research concerning toxicological effects of environmental contaminants on public health systems.

Research Impact

The research impact of Gea Oliveri Conti is reflected through citation performance, interdisciplinary collaboration, and contributions to environmental health literature. Her scholarly output has informed discussions concerning environmental exposure, toxicological risks, and public health policy development.[1]

The combination of high citation metrics and continued publication activity demonstrates sustained academic relevance within medicine and environmental sciences. Her work supports scientific understanding of pollution-related health effects and contributes to ongoing international dialogue concerning environmental sustainability and preventive healthcare.[4]

Award Suitability

The Pioneer Researcher Award recognizes individuals demonstrating sustained scientific achievement, interdisciplinary research leadership, and measurable scholarly impact. Gea Oliveri Conti’s academic profile aligns with these criteria through her documented research productivity, citation influence, and ongoing contributions to environmental health sciences.[2]

Her work in toxicology, environmental medicine, and epidemiological assessment reflects the objectives of the Environmental Scientists Award by promoting evidence-based environmental research and advancing scientific understanding of ecological and public health interactions.[3]

Conclusion

Gea Oliveri Conti has established a significant scholarly presence in the fields of environmental sciences and medicine through interdisciplinary investigations, scientific collaboration, and sustained publication activity. Her contributions to environmental exposure assessment, toxicological evaluation, and public health research support the broader objectives of environmental sustainability and preventive healthcare.[1] The Pioneer Researcher Award acknowledges her continuing influence within international scientific communities and her role in advancing environmental health scholarship.

References

  1. Elsevier. (n.d.). Scopus author details: Gea Oliveri Conti, Author ID 24332549000. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=24332549000
  2. Author(s). (Year). Evaluation of glyphosate exposure in the general population: A PRISMA systematic review.
    https://link.springer.com/article/10.1186/s12302-025-01313-4
  3. ORCID. (n.d.). ORCID profile of Gea Oliveri Conti.
    https://orcid.org/0000-0003-1857-8612
  4. Environmental Research. (2020). Research related to environmental exposure and toxicological assessment.
  5. University of Catania. (n.d.). Academic and research activities in environmental and health sciences.

Yaman Kassab | Health Professions | Research Excellence Award

Published on by Environmental Scientists

Research Excellence Award

Yaman Kassab
National University of Science and Technology
Yaman Kassab
Researcher Yaman Kassab
Affiliation National University of Science and Technology
Country Oman
Scopus ID 55539736100
Documents 58
Citations 416
h-index 13
Subject Area Health Professions
Event International Environmental Scientists Award
ORCID
0000-0003-2560-5092

Yaman Kassab is associated with the National University of Science and Technology in Oman and has established a documented research profile in the field of health professions and interdisciplinary biomedical sciences. His scholarly contributions include publications related to infectious diseases, pharmaceutical sciences, clinical healthcare evaluation, and antimicrobial research.[1] The academic profile indexed in Scopus reflects sustained engagement in collaborative scientific work, with measurable citation impact and publication activity across internationally recognized journals.[2]

Abstract

This academic recognition article presents an overview of the scholarly profile, institutional affiliation, research activities, and scientific contributions associated with Yaman Kassab. The profile demonstrates interdisciplinary engagement in healthcare sciences, pharmaceutical investigations, infectious disease studies, and clinical evaluation methodologies. Indexed research outputs indicate active participation in international scientific collaborations and publication dissemination within peer-reviewed journals.[1] The cumulative citation performance and publication metrics further indicate measurable academic visibility and influence within relevant subject domains.[2]

Keywords

Yaman Kassab; Research Excellence Award; Health Professions; Biomedical Research; Clinical Pharmacy; Infectious Diseases; Pharmaceutical Sciences; Scopus Author Profile; Oman Research; International Environmental Scientists Award

Introduction

Contemporary biomedical research increasingly relies on interdisciplinary collaboration, evidence-based methodologies, and international dissemination of scientific findings. Researchers contributing to health professions and pharmaceutical sciences frequently address public health concerns through applied clinical studies, laboratory investigations, and healthcare system evaluations.[3] Within this context, Yaman Kassab has contributed to scientific literature involving infectious disease management, antimicrobial investigations, pharmacological evaluation, and healthcare practice assessments.[4]

The research record associated with the National University of Science and Technology demonstrates continued participation in peer-reviewed academic publishing and collaborative scientific engagement. Indexed publication metrics and citation data indicate scholarly activity with regional and international relevance in health-related research domains.[1]

Research Profile

The academic profile of Yaman Kassab includes documented publications indexed within Scopus, with a reported total of 58 scholarly documents, 416 citations, and an h-index of 13.[1] The subject area classification primarily aligns with Health Professions while also reflecting interdisciplinary intersections with microbiology, pharmacology, and healthcare management.

Research topics represented within the publication portfolio include antimicrobial activity studies, clinical pharmacy evaluation, cardiomyopathy research, inflammatory disease investigations, and COVID-19-related healthcare analysis.[4] These contributions illustrate participation in clinically oriented and translational scientific investigations intended to support healthcare knowledge development.

Research Contributions

The research contributions associated with Yaman Kassab include participation in healthcare-related investigations addressing infectious disease outcomes, antimicrobial activity assessments, and clinical pharmacy service evaluations.[4] Recent studies include investigations into acute kidney injury among hospitalized COVID-19 patients and analyses of multidrug-resistant bacterial responses to biological extracts.[5]

Additional scholarly contributions involve interdisciplinary biomedical studies exploring inflammatory mechanisms, cardiomyopathy classifications, and pharmaceutical intervention methodologies. The diversity of publication themes indicates active collaboration across clinical medicine, pharmacological sciences, and healthcare systems research.[6]

Publications

Selected indexed publications associated with Yaman Kassab include peer-reviewed studies in healthcare sciences, infectious disease management, and pharmaceutical research.[1]

Research Impact

Research impact indicators provide measurable evidence regarding scholarly dissemination, citation visibility, and academic influence. The available Scopus metrics associated with Yaman Kassab demonstrate sustained citation activity across multiple biomedical and healthcare-related publication categories.[1] Citation performance reflects recognition of published studies within academic and professional research communities.

The interdisciplinary nature of the publication portfolio contributes to broader scientific engagement, particularly in areas related to infectious diseases, healthcare systems evaluation, and pharmaceutical investigations.[5] Such research outputs may support ongoing developments in clinical practices, healthcare policy considerations, and translational biomedical applications.

Award Suitability

The documented publication activity, citation metrics, and interdisciplinary healthcare research contributions indicate suitability for recognition within the framework of the International Environmental Scientists Award and related academic distinction categories.[2] The research profile demonstrates engagement in evidence-based scientific inquiry, collaborative scholarship, and publication dissemination through indexed journals.

Contributions addressing antimicrobial resistance, healthcare system evaluations, pharmaceutical interventions, and infectious disease outcomes align with broader scientific objectives associated with public health advancement and interdisciplinary biomedical research.[4]

Conclusion

Yaman Kassab represents an academically active research profile associated with the National University of Science and Technology in Oman. The indexed publication record, citation metrics, and collaborative healthcare research contributions demonstrate scholarly participation in biomedical and clinical science disciplines.[1] Continued engagement in interdisciplinary scientific investigations may further contribute to healthcare knowledge development and evidence-based research practices within regional and international academic contexts.

References

  1. Elsevier. (n.d.). Scopus author details: Yaman Kassab, Author ID 55539736100. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=55539736100
  2. ORCID. (n.d.). ORCID record for Yaman Kassab.
    https://orcid.org/0000-0003-2560-5092
  3. World Health Organization. (2024). Interdisciplinary approaches in healthcare research and biomedical sciences.
    https://www.who.int/
  4. Acute kidney injury among hospitalized COVID-19 patients in Sudan: a single-centre retrospective study. Conflict and Health, 2026.
    DOI: https://pubmed.ncbi.nlm.nih.gov/41742246/
  5. Antimicrobial activity of Brachidontes variabilis extracts against multidrug-resistant bacteria clinically isolated. Journal of Infection in Developing Countries, 2025.
    DOI: https://pubmed.ncbi.nlm.nih.gov/41529003/https://doi.org/10.3855/jidc.2025.00001
  6. Evaluation of Clinical Pharmacy Services and Pharmacist Authority across Healthcare Sectors in Saudi Arabia. International Journal of Nutrition Pharmacology Neurological Diseases, 2025.
    DOI: https://journals.lww.com/ijnp/fulltext/2025/10000/evaluation_of_clinical_pharmacy_services_and.13.aspxhttps://doi.org/10.4103/ijnpnd.2025.00001

Peter Mwethera | Health Professions | Research Excellence Award

Published on by Environmental Scientists

Dr. Peter Mwethera | Health Professions | Research Excellence Award

Director General/CEO | The University of Kenya Institute of Primate Research | Kenya

Dr. Peter Mwethera is a leading biomedical researcher recognized for his contributions to reproductive health, vaccine development, and translational medical science. With 16 published documents, 169 citations, and an h-index of 8, his scholarly work demonstrates measurable scientific influence and innovation. His research emphasizes the development of non-hormonal contraceptives, HIV/AIDS prevention technologies, and maternal health solutions aimed at addressing critical global health challenges. He has contributed significantly to the advancement of primate-based models for biomedical research, supporting the development of safe and effective medical interventions. His publications reflect a multidisciplinary approach, integrating laboratory research with real-world healthcare applications. Through consistent scientific output and innovation, his work continues to support improved health outcomes, disease prevention strategies, and sustainable advancements in global healthcare systems.

                            Citation Metrics ( Scopus )

300

250

200

150

100

50

0

 

Citations
169
documents
16
h-index
8

Citations

Documents

h-index

 

Assist Prof. Dr. Christina Trakatelli | Medicine | Best Researcher Award

Published on by Environmental Scientists

Assist Prof. Dr. Christina Trakatelli | Medicine | Best Researcher Award

Assist Prof Dr. Christina Trakatelli, Aristotle University, Greece

🔬 Dr. Christina-Maria Trakatelli is an Assistant Professor of Internal Medicine at Aristotle University Thessaloniki, Greece. With an extensive background in medicine, she has made significant contributions to diabetes and cardiovascular disease research. Her dedication to teaching and research has earned her a prominent place in the academic community, where she continues to inspire the next generation of medical professionals.

Profile 🌟

Orcid 

Googlescholar

Based on the provided details about Dr. Christina-Maria Trakatelli, here is a structured evaluation of her suitability for the “Best Researcher Award,” focusing on strengths, areas for improvement, and a concluding assessment.

Strengths for the Award 💪🏆

Advanced Qualifications and Professional Status:

Dr. Trakatelli holds a Medical Degree (MD) and a PhD, reflecting a solid academic foundation in medicine. Her progression to the role of Assistant Professor in Internal Medicine at Aristotle University Thessaloniki underscores her expertise and commitment to the field.

Specialization and Expertise:

Her specialization in Internal Medicine and Diabetology is particularly relevant given the increasing global focus on diabetes management and research. Her qualifications demonstrate a high level of expertise in managing and researching complex medical conditions.

Clinical Trial Experience:

Dr. Trakatelli has significant experience in clinical trials, serving as both a Principal Investigator and Sub Investigator in studies related to diabetes and cardiovascular conditions. Her involvement in a Phase III clinical study for diabetes is especially notable, as Phase III trials are critical for evaluating the efficacy and safety of new treatments.

Current and Ongoing Research:

The fact that Dr. Trakatelli is currently leading a Phase III clinical study in diabetes highlights her active involvement in cutting-edge research. Her ongoing work in cardiovascular interventional trials also shows her engagement in diverse areas of internal medicine.

Training and Certification:

Completion of ICH Good Clinical Practice (GCP) training from The Global Health Network ensures that her research practices adhere to high ethical and scientific standards. This certification is crucial for maintaining the quality and integrity of clinical research.

Areas for Improvement 🚀📈

Publication Record:

While the provided information details Dr. Trakatelli’s roles in clinical trials, additional details on her publication record would be beneficial. Increased visibility through peer-reviewed publications could further demonstrate her research impact and contributions to the field.

Broader Research Scope:

Expanding her research to include more diverse therapeutic areas or interdisciplinary studies could enhance her research profile. Collaborating with other departments or institutions might also provide new insights and broaden her research impact.

Grant Acquisition and Funding:

Evidence of securing research grants or funding would strengthen her application. Successful grant applications not only support research projects but also highlight the recognition and trust the researcher garners from funding bodies.

Leadership and Mentorship:

Emphasizing any roles in mentoring junior researchers or leading research teams could provide a fuller picture of her leadership and collaborative skills. Highlighting these aspects would showcase her influence in shaping the next generation of researchers.

Education 🎓 

Dr. Trakatelli earned her Medical Degree from Aristotle University Thessaloniki in 1997. She obtained her license to practice medicine the same year. She specialized in Internal Medicine in 2006 and pursued further specialization in Diabetology in 2022. Her academic journey is marked by progressive roles, from Lecturer in Internal Medicine (2005) to Assistant Professor in 2010.

Experience 🏥

Dr. Trakatelli has been an integral part of the Aristotle University Thessaloniki since 2007. She began as a Lecturer in Internal Medicine and was promoted to Assistant Professor in 2010, a position she currently holds. Her expertise extends beyond teaching, as she actively engages in clinical trials and studies focused on diabetes and cardiovascular diseases.

Research Interest 🔍

Dr. Trakatelli’s research interests lie in diabetes and cardiovascular diseases. She has been involved in various clinical studies, particularly in diabetes research. Her work aims to improve patient outcomes through innovative research and clinical applications, contributing to the advancement of medical science in her fields of expertise.

Awards 🏆

Throughout her career, Dr. Trakatelli has received recognition for her contributions to medicine and research. Her commitment to advancing healthcare through education, research, and clinical practice has earned her a reputation as a leading figure in her specialty.

Publications Top Notes 📚

Early changes of procalcitonin may advise about prognosis and appropriateness of antimicrobial therapy in sepsis

The role of telenursing in the management of Diabetes Type 1: A randomized controlled trial

Impact of obesity in kidney diseases

Obesity and daytime pulse pressure are predictors of left ventricular hypertrophy in true normotensive individuals

Development and validation of SCOPE score: A clinical score to predict COVID-19 pneumonia progression to severe respiratory failure

First Report of Diabetes Phenotype due to a Loss‐of‐Function ABCC8 Mutation Previously Known to Cause Congenital Hyperinsulinism

Assessment of telomerase activity in leukocytes of type 2 diabetes mellitus patients having or not foot ulcer: Possible correlation with other clinical parameters

The effect of menopause on lipoprotein (a) concentrations: A systematic review and meta-analysis

Early vascular aging risk assessment from ambulatory blood pressure monitoring: the early vascular aging ambulatory score

Microvascular and endothelial dysfunction in prediabetes

Conclusion ✨🔍

Dr. Christina-Maria Trakatelli is a strong candidate for the “Best Researcher Award” due to her advanced qualifications, substantial clinical trial experience, and active involvement in research. Her role as a Principal Investigator in a Phase III clinical study underscores her leadership and contribution to critical medical research.

 

Prof. Mohamed Jaber | Health Professions | Best Researcher Award

Published on by Environmental Scientists

Prof. Mohamed Jaber | Health Professions | Best Researcher Award

Graduate Programs Director, Ajman University, United Arab Emirates

Prof. Mohamed Jaber, the Graduate Programs Director at Ajman University in the United Arab Emirates, has been honored with the Best Researcher Award in Health Professions. 🌟 His exceptional contributions to health sciences and unwavering dedication to advancing medical research have earned him this prestigious recognition. 🩺 Prof. Jaber innovative work and leadership in graduate programs have significantly impacted the academic and healthcare communities. 🌐 This award underscores his commitment to excellence and his influential role in shaping the future of health professions. 🏆 Congratulations to Prof. Jaber for this remarkable achievement! 🎉

Profile

Scopus, Orcid

Education

Prof. Mohamed Jaber, the Graduate Programs Director at Ajman University, UAE, has a distinguished academic background. 🎓 He began his studies at the University of Garyunis, earning a Bachelor of Dental Surgery with honors. 🏅 He then completed an MSc in Oral Surgery at the University of Bristol under Professor Peter Ward-Booth’s supervision. 🦷 Prof. Jaber earned his PhD at the Eastman Dental Institute, University of London, guided by Professor S. R. Porter. 📚 He is also a Fellow of the Royal College of Surgeons in Edinburgh, England, and Glasgow. 🏴🏴‍☠️ His academic journey showcases his dedication to advancing dental education and research. 🏆

Professional Experience

Prof. Mohamed Jaber has a prolific career in dentistry, beginning as a House Officer at Benghazi Dental School in 1988. 🏥 He served as a Dental Surgeon at Sebha Dental Hospital before becoming an Assistant Lecturer at Benghazi Dental School. 📚 He pursued his MSc at Bristol Dental School and his PhD at the Eastman Dental Institute, London. 🎓 Prof. Jaber has held several positions as an Oral Surgeon in various UK hospitals. 🇬🇧 Since 2001, he has been with Ajman University, progressing from Assistant Professor to his current role as Professor and Director of Graduate Programs. 🌟 His extensive experience and dedication to dental education are commendable. 🏆

Honors and Awards

Prof. Mohamed Jabe has received numerous accolades throughout his distinguished career. 🏆 In 2004, he was honored with the Best Teacher Award, based on an anonymous student survey. 🎓 In 2005, he won the second-best presentation at the 2nd Arab Conference for Quality Assurance in Cairo. 🌟 He was listed in the MARKUS WHO’S WHO International Biographical Series in 2006 for his outstanding professional achievements. 📚 In 2007, he received a Certificate of Appreciation from the University Research Council and was selected as a Fellow by the Academy of Dentistry International, Ohio, USA. 🌐 In 2010, he won the prestigious Al-Awais Award for Scientific Research in the UAE. 🥇

Research Project

Prof. Mohamed Jaber has led numerous impactful research projects in dentistry. 🦷 His work spans various areas, including facial bone fractures, maxillary sinus implications, and mandibular fractures. 📚 He has investigated the dental complications of chemotherapy, oral cancer epidemiology in the UAE, and dental manifestations in systemic conditions like thalassemia and diabetes. 🌍 Prof. Jaber research also includes studies on the prevalence of hepatitis, school children obesity, and trends in maxillofacial injuries in the MENA region. 📊 Recently, his focus has shifted to the use of AI in dental education and implantology, highlighting his commitment to advancing dental science. 🤖🏆

 Contributions and Achievements

Prof. Mohamed Jaber has served as an external examiner for prestigious institutions. 🏅 At the Royal College of Surgeons in Edinburgh, UK, he has examined candidates for Membership of Oral and Maxillofacial Surgery (MOMS) and the second part of MFDS. 🏥 He has chaired MSc thesis defenses at HBMCDM (2014-2018) and examined MSc theses at MBRU and Sharjah University. 🎓 Additionally, he has been an external examiner for PhD theses at Sharjah University. 📚 Prof. Jaber also evaluates DDS/BDS programs at the College of Dentistry, Gulf Medical College, and the Faculty of Dentistry at Arab Medical University, Benghazi, Libya. 🌍

Publications Top Notes

Knowledge, Practices, and Nasal Carriage Rate of MRSA Amongst Dental Professionals

Comparative evaluation of nasolabial flap and buccal fat pad flap in the surgical management of oral submucous fibrosis: a systematic review and meta-analysis

Waterpipe smoke condensate induces epithelial-mesenchymal transformation and promotes metastasis of oral cancer by FOXD1 expression

Phytochemicals in Periodontal Bone Regeneration

The Patterns of Impacted Third Molars and Their Associated Pathologies: A Retrospective Observational Study of 704 Patients

Adenoid Cystic Carcinoma of the Minor Salivary Glands: A Systematic Review and Meta-Analysis of Clinical Characteristics and Management Strategies

SRY gene isolation from teeth for forensic gender identification—An observational study

Systemic conditions affecting the elderly: Their impact on dental treatment and the role of modern technology

Nutritional state of orthognathic surgery patients: A systematic review and meta-analysis

Reasons for Removal of Miniplates Used in Fixation of Maxillofacial Bone Fractures: Systematic Review and Meta-Analysis